One of the most important findings in this study is that FH autoantibody levels in stage I are significantly higher than in healthy subjects, but from the perspective of false positive rates, it is difficult to screen for early cancer using FH autoantibodies alone. Here, FH is linked to familial hyperaldosteronism.